meitshels_smell_trades

meitshels_smell_trades

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of...

meitshels_smell_trades Updated 

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are 1) Cholesterol Efflux MediatorTM, VAR 200...

meitshels_smell_trades

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK...

meitshels_smell_trades

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma. This is not a financial advice! 2 upcoming catalysts on 31st...

meitshels_smell_trades Updated 

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting...

meitshels_smell_trades Updated 

Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates. This is not a financial advice! Upcoming catalyst on 31st. of March We need to stay in a bullish overal sentiment of...

meitshels_smell_trades Updated 

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other...

meitshels_smell_trades Updated 

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue...

meitshels_smell_trades Updated 

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders,...

meitshels_smell_trades Updated 

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions...

meitshels_smell_trades Updated 

This is not a financial advice! Upcoming catalyst end of Feb 2024 Expecting a pre run up into the event. Low float of 4.83M SL under 6.3 TP approx. 13 If the catalysts will be positive, this can fly way higher! Most info on the chart. Trade carefully!

meitshels_smell_trades Updated 

This is not a financial advice! Lots of upcoming catalysts in 2024 Vol . is slowly increasing SL under 2.2 TP approx. 9.0 If the catalysts will be positive, this can fly way higher! Most info on the chart. Trade carefully!

meitshels_smell_trades

This is not a financial advice! Expecting a big move on this hidden gem. Low float of 4.99M SL under 8.3 TP approx. 19 maybe even 26 Most info on the chart. Trade carefully!

meitshels_smell_trades

This is not a financial advice! Maybe a hidden BTC gem The9 Shares Rise 11% After CEO Plans to Buy Up to 10% of ADSs SL under 4.0 TP approx. 7.0 / maybe 9.0 Low float of 2.82M Most info on the chart. Trade carefully!

meitshels_smell_trades

Expecting a pre run up into the FDA event. We are having a gap arround 10. Lots of recent block buys and kind of a middle high short float.

meitshels_smell_trades Updated 

This is not a financial advice! Possible next AI runner - "FiscalNote Announces Continued Ai Innovation And Momentum With Receipt Of 13th Patent From U.S. Patent Office* Key zone 2.86 SL under 1.7 TP1 around 5 TP2 around 6.5 Most info on the chart. Trade carefully!

meitshels_smell_trades

This is not a financial advice! Not much chart data available If we ever get back down to 4.3 area I would load the boat. China ChatGPT version! Trade carefully!

meitshels_smell_trades

This is not a financial advice! Vol . is slowly increasing SL under 1.10 or if u want more risk under 0.9 TP 1.8 to 2.0 Most info on the chart. Trade carefully!